| The best trading indicator for TSLA (ad) |
Rarely do I label something as "the best'
But in this rare instance, I believe this is THE BEST indicator for trading Tesla's stock.
Except, it's not another tech stock…
But rather a stock hiding in broad daylight…
Click this link here. |
|
| Get These Top Performing Stocks At A Discount Right Now! (ad) |
As you know, the stock market has been volatile lately, and there's a lot of uncertainty in the air. But we want to assure you that this is not the time to panic. In fact, it's the time to be buying stocks.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
Download Our Free Report Here |
|
 Apple Inc. (AAPL)    Amazon.com, Inc. (AMZN)  - Director Jonathan Rubinstein sold 5,556 shares of Amazon.com stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $180.00, for a total transaction of $1,000,080.00. Following the sale, the director now directly owns 109,664 shares of the company's stock, valued at approximately $19,739,520. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
- CEO Andrew R. Jassy sold 50,000 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $180.00, for a total value of $9,000,000.00. Following the completion of the transaction, the chief executive officer now owns 1,994,182 shares of the company's stock, valued at approximately $358,952,760. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
- (3/7) Surging Stocks: These Music Industry Picks See Boost After Exceeding Expectations - Exchange Traded Concepts Trust MUSQ Global Music Industry ETF (ARCA:MUSQ) (benzinga.com)
- (3/7) Amazon CEO Andy Jassy sells shares worth $9 million (seekingalpha.com)
- (3/7) Amazon's rightsized and regionalized fulfillment strategy set to deliver more profits and more stock gains ahead (cnbc.com)
- (3/7) Amazon.com, Inc. (NASDAQ:AMZN) Shares Purchased by Mariner LLC (marketbeat.com)
- (3/6) Amazon's AWS To Launch An Infrastructure Region In Saudi Arabia (markets.businessinsider.com)
- (3/6) Looking Ahead to Q1 Earnings: What's Next? (zacks.com)
- (3/6) Looking Ahead to Q1 Earnings: What's Next? (zacks.com)
- (3/6) Microsoft To End Support For Amazon's Android App Store On Windows 11 (markets.businessinsider.com)
- (3/6) Amazon's AWS Scraps Exit Fees, Freeing Data Transfers to Rival Cloud Services (msn.com)
 Barker Minerals Ltd (BML)   Meta Platforms, Inc. (META)  - CEO Mark Zuckerberg sold 77,412 shares of Meta Platforms stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $497.61, for a total transaction of $38,520,985.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
- CEO Mark Zuckerberg sold 77,412 shares of Meta Platforms stock in a transaction on Monday, March 4th. The stock was sold at an average price of $500.60, for a total transaction of $38,752,447.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
- (3/7) Crestwood Advisors Group LLC Sells 37,366 Shares of Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (3/7) Is Facebook still down? Meta platforms, including Instagram and Messenger, coming back up. (msn.com)
- (3/7) The Top 7 Stocks to Buy in March 2024 (investorplace.com)
- (3/7) 2 Trillion-Dollar "Magnificent Seven" Stocks to Buy Hand Over Fist in March (fool.com)
- (3/6) For social platforms, the outage was short. But people's stories vanished, and that's no small thing (msn.com)
- (3/6) For social platforms, the outage was short. But people's stories vanished, and that's no small thing (marketbeat.com)
- (3/6) Temu's Push Into America Pays Off Big Time for Meta and Google (wsj.com)
- (3/6) Deepfake ads featuring Jenna Ortega ran on Meta platforms. Big Tech needs to fight this. (msn.com)
- (3/6) Looking Ahead to Q1 Earnings: What's Next? (zacks.com)
- (3/6) Looking Ahead to Q1 Earnings: What's Next? (zacks.com)
 Microsoft Co. (MSFT)  - Akamai Technologies (NASDAQ:AKAM) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $135.00 price target on the stock, up previously from $128.00. This represents a 21.3% upside from the current price of $111.34.
- Emergent BioSolutions (NYSE:EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock. This represents a 81.8% upside from the current price of $2.75.
- Enhabit (NYSE:EHAB) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating. They now have a $9.50 price target on the stock. This represents a 2.7% downside from the current price of $9.76.
- EVgo (NYSE:EVGO) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock, down previously from $5.00. This represents a 36.1% upside from the current price of $2.94.
- Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.The current price is $91.93.
- Micron Technology (NASDAQ:MU) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $120.00 price target on the stock, up previously from $80.00. This represents a 21.1% upside from the current price of $99.13.
- SBA Communications (NASDAQ:SBAC) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $260.00 price target on the stock. This represents a 19.0% upside from the current price of $218.53.
- Shake Shack (NYSE:SHAK) was upgraded by analysts at TD Cowen from a "market perform" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $91.00. This represents a 21.2% upside from the current price of $103.17.
- Sherwin-Williams (NYSE:SHW) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $402.00 price target on the stock, up previously from $312.00. This represents a 16.9% upside from the current price of $343.77.
- Silk Road Medical (NASDAQ:SILK) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. This represents a 44.5% upside from the current price of $16.61.
- Toast (NYSE:TOST) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating. They now have a $30.00 price target on the stock. This represents a 21.6% upside from the current price of $24.68.
- View today's most recent analysts' upgrades at MarketBeat.com
| The Ultimate Passive Income Play (ad) |
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.
Find Out What It Is Right Here |
|
- Cogent Communications (NASDAQ:CCOI) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $75.00 price target on the stock, down previously from $85.00. This represents a 9.0% upside from the current price of $68.79.
- TriplePoint Venture Growth BDC (NYSE:TPVG) was downgraded by analysts at Compass Point from a "neutral" rating to a "sell" rating. They now have a $8.75 price target on the stock. This represents a 6.6% downside from the current price of $9.37.
- View today's most recent analysts' downgrades at MarketBeat.com
| 6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company (ad) |
|
- Arcellx (NASDAQ:ACLX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $81.00 price target on the stock. This represents a 9.8% upside from the current price of $73.76.
- Broadstone Net Lease (NYSE:BNL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $14.00 price target on the stock. This represents a 4.3% downside from the current price of $14.63.
- Catalyst Pharmaceuticals (NASDAQ:CPRX) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $23.00 price target on the stock. This represents a 42.0% upside from the current price of $16.20.
- Dominion Diamond (NYSE:DDC) (TSE:DDC) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock. This represents a 115.8% upside from the current price of $1.39.
- Despegar.com (NYSE:DESP) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $11.00 price target on the stock. This represents a 18.7% upside from the current price of $9.27.
- Edgewise Therapeutics (NASDAQ:EWTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $48.00 price target on the stock. This represents a 174.8% upside from the current price of $17.47.
- JFrog (NASDAQ:FROG) is now covered by analysts at Scotiabank. They set a "buy" rating on the stock.The current price is $43.01.
- Galapagos (NASDAQ:GLPG) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $38.00 price target on the stock. This represents a 10.0% upside from the current price of $34.53.
- Jack Henry & Associates (NASDAQ:JKHY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $173.63.
- MiMedx Group (NASDAQ:MDXG) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $12.00 price target on the stock. This represents a 47.2% upside from the current price of $8.15.
- Pacira BioSciences (NASDAQ:PCRX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $45.00 price target on the stock. This represents a 47.4% upside from the current price of $30.52.
- ProKidney (NASDAQ:PROK) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $3.00 price target on the stock. This represents a 70.0% upside from the current price of $1.77.
- Rivian Automotive (NASDAQ:RIVN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $16.00 price target on the stock. This represents a 41.7% upside from the current price of $11.29.
- TKO Group (NYSE:TKO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $102.00 price target on the stock. This represents a 26.1% upside from the current price of $80.90.
- Viking Therapeutics (NASDAQ:VKTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $110.00 price target on the stock. This represents a 40.8% upside from the current price of $78.12.
- Voyager Therapeutics (NASDAQ:VYGR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $16.00 price target on the stock. This represents a 70.9% upside from the current price of $9.36.
- Zealand Pharma A/S (OTCMKTS:ZLDPF) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.The current price is $99.70.
- View today's most recent analysts' new coverage at MarketBeat.com
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL  |
|
| Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
| VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
| JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: The World's First "$20 Trillion Drug"? |
|
No comments:
Post a Comment